• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Health Secur . Estimated Airline Compliance With Predeparture SARS-CoV-2 Testing for Passengers on Flights to the United States, January 2021 to Ju

tetano

Editor, Senior Moderator
Health Secur


. 2024 Sep-Oct;22(5):398-401.
doi: 10.1089/hs.2023.0130. Epub 2024 Sep 18. Estimated Airline Compliance With Predeparture SARS-CoV-2 Testing for Passengers on Flights to the United States, January 2021 to June 2022

Leigh Ellyn Preston[SUP] 1 [/SUP], Andre Berro[SUP] 1 [/SUP], Deborah Christensen[SUP] 1 [/SUP], Bukunmi Gesinde[SUP] 1 [/SUP], Arnold Vang[SUP] 1 [/SUP], Candice Gilliland[SUP] 1 [/SUP], Kelly J Epps[SUP] 1 [/SUP], Erin Rothney[SUP] 1 [/SUP], Matt Palo[SUP] 1 [/SUP], Andrew D Klevos[SUP] 1 [/SUP], James R Cope[SUP] 1 [/SUP], Zoe D'Angelo[SUP] 1 [/SUP], John Olmstead[SUP] 1 [/SUP], Emma Shearer[SUP] 1 [/SUP], Bhavna Guduguntla[SUP] 1 [/SUP], Josie Decherd[SUP] 1 [/SUP], Clive Brown[SUP] 1 [/SUP], Alida M Gertz[SUP] 1 [/SUP]



Affiliations
Abstract

In the early years of the COVID-19 pandemic, unprecedented public health measures were designed and implemented to mitigate the spread of SARS-CoV-2. On January 26, 2021, US Centers for Disease Control and Prevention (CDC) staff began daily audits of documents of arriving passengers at 18 US international ports of entry to ensure documentation of either a negative predeparture antigen or nucleic acid amplification test result for SARS-CoV-2 or recent recovery from COVID-19. This case study briefly describes the results of those audits. The CDC found a very low rate of issues overall. Of the 483,251 passengers selected for audit, 2,142 (0.44%) had issues with their COVID-19 test documentation and 1,182 (0.24%) provided documentation of recovery from COVID-19 rather than a negative test result. The low rate of issues noted during traveler audits indicated airlines were largely compliant with the order. However, the burden of SARS-CoV-2 infections within the United States was high during much of this period, which suggests that implementing a predeparture testing requirement earlier in the pandemic might have had more impact on spread. Digital solutions could reduce the burden of similar interventions in the future on airlines, public health authorities, and other partners.

Keywords: COVID-19; Epidemic management/response; National strategy/policy; Ports of entry; Public health preparedness/response; SARS-CoV-2; Travel health.

 
Back
Top Bottom